TCL Archive NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms February 8, 1980
TCL Archive Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer February 25, 2011
TCL Archive Cooperative Groups Fight Back: Members Seek Move To Multidisciplinary Approach, More Funds May 30, 1975
TCL Archive Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies June 25, 2010
